MINNEAPOLIS, Oct. 23 (UPI) -- A U.S. study has determined why episodic treatment of the human immunodeficiency virus and AIDS with anti-retroviral drugs increases the overall risk of death.
James Neaton of the University of Minnesota and colleagues said it was known intermittent HIV/AIDS treatment was tied to inflammation and blood-clotting when compared with continuous antiretroviral treatment, or ART. But the reasons for that were unknown.
Neaton and colleagues have discovered higher levels of certain markers of inflammation and blood-clotting are strongly associated with intermittent ART and with a higher risk of death from non-AIDS diseases.
The scientists said they determined people who began the study with relatively higher levels of the biomarkers interleukin-6 and D-dimer were at greater risk of death than other study participants.
The new research appears in the journal PLoS Medicine.
| Additional News Stories | |
WASHINGTON, Nov. 10 (UPI) --
John Allen Muhammad, the so-called D.C. Sniper, died by lethal injection at a Virginia prison at 9:11 p.m. Tuesday, a prison official said.
|
LOS ANGELES, Nov. 10 (UPI) --
Lead singer Steven Tyler does not intend to quit the rock group Aerosmith, contrary to rumors claiming he already has, sources told The Hollywood Reporter.
|
|
|